142 related articles for article (PubMed ID: 17581265)
1. Budesonide in the treatment of refractory celiac disease.
Brar P; Lee S; Lewis S; Egbuna I; Bhagat G; Green PH
Am J Gastroenterol; 2007 Oct; 102(10):2265-9. PubMed ID: 17581265
[TBL] [Abstract][Full Text] [Related]
2. Open-Capsule Budesonide for Refractory Celiac Disease.
Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine in refractory sprue: results from a prospective, open-label study.
Mauriño E; Niveloni S; Cherñavsky A; Pedreira S; Mazure R; Vazquez H; Reyes H; Fiorini A; Smecuol E; Cabanne A; Capucchio M; Kogan Z; Bai JC
Am J Gastroenterol; 2002 Oct; 97(10):2595-602. PubMed ID: 12385445
[TBL] [Abstract][Full Text] [Related]
4. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
5. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
6. Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
[TBL] [Abstract][Full Text] [Related]
7. Oral budesonide in the treatment of chronic refractory pouchitis.
Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
[TBL] [Abstract][Full Text] [Related]
8. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
9. Features of Adult Autoimmune Enteropathy Compared With Refractory Celiac Disease.
Sharma A; Choung RS; Wang XJ; Russo PA; Wu TT; Nehra V; Murray JA
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):877-883.e1. PubMed ID: 29307846
[TBL] [Abstract][Full Text] [Related]
10. The value of double-balloon enteroscopy in patients with refractory celiac disease.
Hadithi M; Al-toma A; Oudejans J; van Bodegraven AA; Mulder CJ; Jacobs M
Am J Gastroenterol; 2007 May; 102(5):987-96. PubMed ID: 17378908
[TBL] [Abstract][Full Text] [Related]
11. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
12. Budesonide in Crohn's disease: findings of a compassionate-use program.
Lyckegaard E; Håkansson K; Bengtsson B
Hepatogastroenterology; 2007; 54(79):2024-7. PubMed ID: 18251152
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
14. Role of immunosuppressive therapy in refractory sprue-like disease.
Rolny P; Sigurjonsdottir HA; Remotti H; Nilsson LA; Ascher H; Tlaskalova-Hogenova H; Tuckova L
Am J Gastroenterol; 1999 Jan; 94(1):219-25. PubMed ID: 9934759
[TBL] [Abstract][Full Text] [Related]
15. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis.
Kanowitz SJ; Batra PS; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):131-6. PubMed ID: 18585575
[TBL] [Abstract][Full Text] [Related]
16. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
17. Therapy with budesonide in patients with refractory sprue.
Daum S; Ipczynski R; Heine B; Schulzke JD; Zeitz M; Ullrich R
Digestion; 2006; 73(1):60-8. PubMed ID: 16612091
[TBL] [Abstract][Full Text] [Related]
18. Large granular lymphocytic leukemia: a treatable form of refractory celiac disease.
Malamut G; Meresse B; Verkarre V; Kaltenbach S; Montcuquet N; Duong Van Huyen JP; Callens C; Lenglet J; Rahmi G; Samaha E; Ranque B; Macintyre E; Radford-Weiss I; Hermine O; Cerf-Bensussan N; Cellier C
Gastroenterology; 2012 Dec; 143(6):1470-1472.e2. PubMed ID: 22922421
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
[TBL] [Abstract][Full Text] [Related]
20. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
